Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yujin Hoshida

Showing results (121-130 of 263) with videos related to

Pageof 27
Sort By:
Experimental Hematology|November 4, 2019
Shared and Tissue-Specific Expression Signatures between Bone Marrow from Primary Myelofibrosis and Essential ThrombocythemiaGenta Ishikawa, Naoto Fujiwara, Hadassa Hirschfield, et al.
Gastroenterology|March 9, 2023
A Therapeutically Targetable TAZ-TEAD2 Pathway Drives the Growth of Hepatocellular Carcinoma via ANLN and KIF23Yoshinobu Saito, Dingzi Yin, Naoto Kubota, et al.
Heliyon|February 22, 2020
Somatic mutation landscape reveals differential variability of cell-of-origin for primary liver cancerKyungsik Ha, Masashi Fujita, Rosa Karlić, et al.
Cancers|December 11, 2025
Performance of GAAD and GALAD Biomarker Panels for HCC Detection in Patients with MASLD or ALD CirrhosisMohammad Jarrah, Sneha Deodhar, Lisa Quirk, et al.
Cancer Research|January 7, 2006
Topological and functional discovery in a gene coexpression meta-network of gastric cancerAmit Aggarwal, Dong Li Guo, Yujin Hoshida, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 9, 2020
Thrombocytosis is associated with worse survival in patients with hepatocellular carcinomaPo-Hong Liu, Chia-Yang Hsu, Chien-Wei Su, et al.
Journal of Hepatology|February 28, 2023
International Liver Cancer Association (ILCA) white paper on hepatocellular carcinoma risk stratification and surveillanceAmit G Singal, Marco Sanduzzi-Zamparelli, Pierre Nahon, et al.
Journal of Hepatology|February 11, 2012
Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenibAnja Lachenmayer, Sara Toffanin, Laia Cabellos, et al.
Hepatology International|August 12, 2009
Changes in hepatic functional reserve after percutaneous tumor ablation for hepatocellular carcinoma: long-term follow up for 227 consecutive patients with a single lesionYukihiro Koike, Haruhiko Yoshida, Shuichiro Shiina, et al.
The Journal of Infectious Diseases|June 18, 2005
Hepatitis C virus core protein and hepatitis activity are associated through transactivation of interleukin-8Yujin Hoshida, Naoya Kato, Hideo Yoshida, et al.
Pageof 27

Showing results (121-130 of 263) with videos related to

Sort By:
Pageof 27
Experimental Hematology|November 4, 2019
Shared and Tissue-Specific Expression Signatures between Bone Marrow from Primary Myelofibrosis and Essential ThrombocythemiaGenta Ishikawa, Naoto Fujiwara, Hadassa Hirschfield, et al.
Gastroenterology|March 9, 2023
A Therapeutically Targetable TAZ-TEAD2 Pathway Drives the Growth of Hepatocellular Carcinoma via ANLN and KIF23Yoshinobu Saito, Dingzi Yin, Naoto Kubota, et al.
Heliyon|February 22, 2020
Somatic mutation landscape reveals differential variability of cell-of-origin for primary liver cancerKyungsik Ha, Masashi Fujita, Rosa Karlić, et al.
Cancers|December 11, 2025
Performance of GAAD and GALAD Biomarker Panels for HCC Detection in Patients with MASLD or ALD CirrhosisMohammad Jarrah, Sneha Deodhar, Lisa Quirk, et al.
Cancer Research|January 7, 2006
Topological and functional discovery in a gene coexpression meta-network of gastric cancerAmit Aggarwal, Dong Li Guo, Yujin Hoshida, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 9, 2020
Thrombocytosis is associated with worse survival in patients with hepatocellular carcinomaPo-Hong Liu, Chia-Yang Hsu, Chien-Wei Su, et al.
Journal of Hepatology|February 28, 2023
International Liver Cancer Association (ILCA) white paper on hepatocellular carcinoma risk stratification and surveillanceAmit G Singal, Marco Sanduzzi-Zamparelli, Pierre Nahon, et al.
Journal of Hepatology|February 11, 2012
Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenibAnja Lachenmayer, Sara Toffanin, Laia Cabellos, et al.
Hepatology International|August 12, 2009
Changes in hepatic functional reserve after percutaneous tumor ablation for hepatocellular carcinoma: long-term follow up for 227 consecutive patients with a single lesionYukihiro Koike, Haruhiko Yoshida, Shuichiro Shiina, et al.
The Journal of Infectious Diseases|June 18, 2005
Hepatitis C virus core protein and hepatitis activity are associated through transactivation of interleukin-8Yujin Hoshida, Naoya Kato, Hideo Yoshida, et al.
Pageof 27